Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17... by Sargos, Paul, MD, Chabaud, Sylvie, MSc, Latorzeff, Igor, MD, Magné, Nicolas, Prof, Benyoucef, Ahmed, MD, Supiot, Stéphane, Prof, Pasquier, David, MD, Abdiche, Menouar Samir, MD, Gilliot, Olivier, MD, Graff-Cailleaud, Pierre, MD, Silva, Marlon, MD, Bergerot, Philippe, MD, Baumann, Pierre, MD, Belkacemi, Yazid, Prof, Azria, David, Prof, Brihoum, Meryem, MSc, Soulié, Michel, Prof, Richaud, Pierre, MD

Get full text

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial by Gravis, Gwenaelle, Dr, Fizazi, Karim, Prof, Joly, Florence, Prof, Oudard, Stéphane, Prof, Priou, Franck, MD, Esterni, Benjamin, MSc, Latorzeff, Igor, MD, Delva, Remy, MD, Krakowski, Ivan, Prof, Laguerre, Brigitte, MD, Rolland, Fréderic, MD, Théodore, Christine, MD, Deplanque, Gael, MD, Ferrero, Jean Marc, Prof, Pouessel, Damien, MD, Mourey, Loïc, MD, Beuzeboc, Philippe, MD, Zanetta, Sylvie, MD, Habibian, Muriel, Berdah, Jean François, MD, Dauba, Jerome, MD, Baciuchka, Marjorie, MD, Platini, Christian, MD, Linassier, Claude, Prof, Labourey, Jean Luc, MD, Machiels, Jean Pascal, Prof, El Kouri, Claude, MD, Ravaud, Alain, Prof, Suc, Etienne, MD, Eymard, Jean Christophe, MD, Hasbini, Ali, MD, Bousquet, Guilhem, MD, Soulie, Michel, Prof

Get full text

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomise... by Pfister, Christian, Prof, Gravis, Gwenaelle, MD, Flechon, Aude, MD, Chevreau, Christine, MD, Mahammedi, Hakim, MD, Laguerre, Brigitte, MD, Guillot, Aline, MD, Joly, Florence, Prof, Soulie, Michel, Prof, Allory, Yves, Prof, Harter, Valentin, MSc, Culine, Stéphane, Prof

Get full text

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised... by Bidard, François-Clément, Prof, Hardy-Bessard, Anne-Claire, MD, Dalenc, Florence, Prof, Bachelot, Thomas, MD, Pierga, Jean-Yves, Prof, de la Motte Rouge, Thibault, MD, Sabatier, Renaud, MD, Dubot, Coraline, MD, Frenel, Jean-Sébastien, MD, Ferrero, Jean Marc, Prof, Ladoire, Sylvain, Prof, Levy, Christelle, MD, Mouret-Reynier, Marie-Ange, MD, Lortholary, Alain, MD, Grenier, Julien, MD, Chakiba, Camille, MD, Stefani, Laetitia, MD, Plaza, Jérôme Edouard, MD, Clatot, Florian, Prof, Teixeira, Luis, Prof, D'Hondt, Véronique, MD, Vegas, Hélène, MD, Derbel, Olfa, MD, Garnier-Tixidre, Claire, MD, Canon, Jean-Luc, MD, Pistilli, Barbara, MD, André, Fabrice, Prof, Arnould, Laurent, MD, Pradines, Anne, PhD, Bièche, Ivan, Prof, Callens, Céline, PharmD, Lemonnier, Jérôme, PhD, Berger, Frédérique, MSc, Delaloge, Suzette, MD

Get full text